Loading...
•
Jun 30, 2022
CVS Health Q2 2022 Earnings Report
Reported strong second quarter results and raised 2022 full-year EPS and cash flow from operations guidance.
Key Takeaways
CVS Health's total revenues increased to $80.6 billion, up 11.0% compared to prior year. GAAP diluted EPS was $2.23 and Adjusted EPS was $2.40. The company raised its full-year 2022 GAAP diluted EPS guidance range to $7.23 to $7.43 from $6.93 to $7.13 and raised its full-year 2022 Adjusted EPS guidance range to $8.40 to $8.60 from $8.20 to $8.40. The company also raised its full-year 2022 cash flow from operations guidance range to $12.5 billion to $13.5 billion from $12.0 billion to $13.0 billion.
Total revenues increased to $80.6 billion, up 11.0% compared to prior year
GAAP diluted EPS of $2.23 and Adjusted EPS of $2.40
Paid down $1.5 billion of long-term debt
Enrolled six million active users on the Company’s individualized Health Dashboard since its launch earlier this year.
Revenue by Segment
Forward Guidance
The Company raised its full-year 2022 GAAP diluted EPS guidance range to $7.23 to $7.43 from $6.93 to $7.13 and raised its full-year 2022 Adjusted EPS guidance range to $8.40 to $8.60 from $8.20 to $8.40. The Company also raised its full-year 2022 cash flow from operations guidance range to $12.5 billion to $13.5 billion from $12.0 billion to $13.0 billion.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...